Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Satu Visi Putra Tbk. (VISI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Satu Visi Putra Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume), while Satu Visi Putra Tbk. trades at Rp985 (market cap 2.84T, 592.3K 24h volume). The key difference: Satu Visi Putra Tbk. is far larger — about 17.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Satu Visi Putra Tbk. is more actively traded (592.3K versus 43.9K). Which is the better fit depends on your goals.
| OBAT | VISI | |
|---|---|---|
Market Cap | 164.65B | 2.84T |
Volume | 43.9K | 592.3K |
Lot | 439 | 5.92K |
Turnover | 10.6M | 573.84M |
Average Price | 241.43 | 968.84 |
Value | 10.6M | 573.84M |
Indicative Equilibrium Price | 238 | 925 |
Indicative Equilibrium Volume | 100 | 2.1K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Satu Visi Putra Tbk.
PT Satu Visi Putra Tbk (the Entity) was established based on Deed No. 16, dated February 14, 2018 of Soeprayitno, S.H., notary in Surabaya. The Entity started its commercial operation in 2018.
Read more on VISI →
